john h. rundback, m.d., fsir, fsvmb, faha · editorial board, endovascular today, 6/06 – present...

JOHN H. RUNDBACK M.D. www.hopeforfibroids.org - 1 -

John H. Rundback, M.D., FSIR, FSVMB, FAHA

1) Date of Preparation of C.V.: February 2011

2) Academic Training

College: CUNY Brooklyn College

Seven-year BA-MD Program

Phi Beta Kappa, Magna Cum Laude

Bachelor of Arts with Honors, Chemistry, 1983

Medical School: SUNY Downstate Medical Center, M.D., 5/83-5/87

3) Medical Training

Internship: Transitional Internship, 6/87-6/88

St. Vincent‟s Hospital and Medical Center

New York, New York

Residency: Diagnostic Radiology Residency, 7/88-6/92

Chief Resident, 1991-1992

Beth Israel Medical Center

New York, New York

Fellowship: Interventional Radiology Fellowship

Washington Hospital Center, Washington, D.C.

7/92-6/93

4) Board Qualification

Diplomate, American Board of Radiology, June 1992

Certificate of Added Qualification, Angiography and Interventional Radiology,

February 1995, recertification January 2006

5) Professional Organizations and Societies Society of Cardiovascular and Interventional Radiology

(Fellow of the Society – October 2001)

American Heart Association (Fellow – December 2003)

Society of Vascular Medicine and Biology (Fellow – January 2006)

Radiological Society of North America

American College of Radiology


N.Y.S. Roentgen Ray Society

Cardiovascular and Interventional Radiology Society of Europe

6) Academic Appointments

College of Physicians and Surgeons of Columbia University

New York, N.Y

Director of Clinical Research, Vascular and Interventional Radiology

Associate Professor of Clinical Radiology, August 2001 – August 2005

Adjunct Associate Professor of Clinical Radiology, August 2005 – present

New York Medical College

Valhalla, N.Y.

Associate Clinical Professor of Radiology and Surgery, February 2000 – August 2001 Director of Clinical Research, Vascular Health Center Assistant Professor, April 1995 – August 2001

7) Hospital and Professional Appointments

Managing Partner,

Advanced Interventional Radiology

Services, LLP

Director, Interventional Institute

Holy Name Hospital

Teaneck, NJ

August 2005 – present

Partner, Manhattan Interventional

Radiology, LLP, 2009-present

Managing Partner, Hudson

Interventional Radiology, PC, 2010-

Medical Director,

Vascular Access Center Jersey City,

2010 –

Associate Attending Radiologist

New York Presbyterian Hospital

Lawrence Hospital

Bronxville, N.Y.

August 2001 – August 2005

Westchester Medical Center

Valhalla, N.Y.

April 1995 – August 2001

Danbury Hospital

Danbury, CT.

June 2000 – August 2001

Muhlenberg Hospital Center

Bethlehem, Pa.

July 1993 – February 1995

New York, N.Y.

August 2001- July 2005

8) Honors and Appointments

Patient Safety Committee, Holy Name Hospital 2009-present

Cancer Committee, Holy Name Hospital 2008-present

Credentialing Committee, Holy Name Hospital, 2009-present


Board of Directors, Society of Interventional Radiology Foundation 2000-2009

Founder and Network Chair, Society of Interventional Radiology Foundation

Cooperative Alliance for Interventional Research Clinical Trials Network (CAIRR)

2003 – 2009

(projects developed: Trans Atlantic Asymptomatic Carotid Intervention Trial, Venous

Thrombolysis v. Medical Therapy Trial, Evaluation of Ovarian and Endometrial

Function after Uterine Artery Embolization, Research Consensus Panels completed on

Skeletal Interventions and Interventional Oncology)

o Moderator, Research Consensus Panels for Skeletal Interventions, Lung

Interventional Oncology, Liver Interventional Oncology, Uterine Artery

Embolization, Venous Interventions, CV Imaging, IVC filtration

o Chair, Peripheral Arterial Disease Research Consensus Panel 2008

Division Councilor, SIR Foundation Clinical Trials Division 2004 – 2009

Member, American College of Cardiology Carotid Expert Consensus Document

Development team, 2005 – 2006

Member, Agency for Healthcare Quality and Research (AHRQ) Technical Expert

Panel for development of evidence based recommendations for renal interventions

Editorial Board, Journal of Vascular and Interventional Radiology, 10/04 – present

Editorial Board, Catheterization and Cardiovascular Interventions, 9/06 – present

Editorial Board, Endovascular Today, 6/06 – present

Examiner for 2004 ABR VIR Certificate of Added Qualification examination

Chairman, SCVIR / CIRREF Research Committee 2000-2003

Columbia Presbyterian Medical Center Radiology Sadek K. Hilal Faculty Research

Award, 6/2003

Chairman, Johnson & Johnson Cordis Endovascular CYPHER Advisory Board

(Peripheral Drug-eluting stent program), 2001-2003

Member, Peripheral Vascular Advisory Board, Medtronic, 2001-2003

Member, Scientific Advisory Board, Boston Scientifics Corp, Cryovascular Inc, 2002-

2003

Member, Advisory Board – The Medicines Company, 2003

Member, SCVIR Subcommittee to Define Complications and Success

SCVIR Technology Assessment Committee (TAC)

Chair, SCVIR TAC working group on reporting standards for renal interventions

Chair, AHA writing group on renal revascularization reporting in clinical trials

AHA Peer Review Study Group Member

SCVIR/FDA Device Forum Committee

ACRIN Ablation Therapy Workgroup

American Heart Association Council on Cardiovascular Radiology

American Heart Association Atherosclerotic Vascular Disease Working Group on

Pathophysiology

Research and Technology Assessment (RTA) Committee, Commission on

Interventional and Cardiovascular Radiology, American College of Radiology

Member, Interventional Radiology Ad Hoc Committee of the New York State

Radiological Society, Inc.


Member, CSC Subcommittee for the Practice Guidelines for the Performance of

Angiography, Angioplasty, and Stenting for the Diagnosis and Treatment of Renal

Artery Stenosis

Member, Clinical Events Committee – Cordis/Quantum AAA trial

Active Consulting Work

Chair, Data Safety Monitoring Board (DSMB) – VPI Excell Tibial Stent Trial

Member, Data Safety Monitoring Board (DSMB) – Angiotech Paclitaxel Vascular

Wrap in Hemodialysis Graft Trial

Member, Data Safety Monitoring Board (DSMB) – EV3 “DURABILITY” SFA stent

trial

Scientific Advisory Board – Flowmedica Inc. (now Angiodynamics)

Scientific Advisory Board – Rafael Medical

Scientific Advisory Board – ev3 Inc.

Scientific Advisory Board – EKOS Inc.

Consultant – Medtronic Renal Stent Trial Development and Iliac stent trial

Consultant – Invatec Inc. (Now Medtronic)

Consultant – ev3 antirestenosis strategy group (Now Covidien)

Consultant – Biosphere (Now Merit)

Medical Advisory Board – HeartHealthyWomen.Org

9) Grant Support and Research Activities

Active:

1. US Principal Investigator, Medtronic Iliac Stent Trial

2. Site PI, CHOICE trial, Abbot PMS carotid stent trial

3. Site PI, Trivascular AAA trial

4. Principal Investigator (Chair, Executive Committee) – Trans Atlantic Asymptomatic

Carotid Intervention Trial (TACIT). Collaborative NIH RO1 and European Union

Grant Application currently in preparation. Three arm pivotal trial evaluating best

medical therapy, carotid stenting and carotid stenting in all risk asymptomatic patient

with >80% ICA stenosis.

5. Clinical Outcomes in Renal Artery Lesions (CORAL) trial –

3/2004 NHLBI RO1

Member, Steering Committee

Chair, Interventional Management Committee

Principal Investigator, Holy Name Hospital

Completed:

1. U.S. Principal Investigator, CVR002, Phase I/II Trial Of ABI-007 (Albumin

Nanoparticle Paclitaxel) For The Prevention Of Restenosis Following Revascularization

Of The Superficial Femoral Artery

Sponsor: American Biosciences

IND number: 63,082


2. Site Principal Investigator. SafeFlow IVC Filter Trial. Sponsor: Rafael Medical

3. Hemodynamic Effects and Target Renal Parenchymal Damage during Protected

Renal Angioplasty Using a Temporary Occlusive Device in a Pig Model of Renal

Artery Stenosis. Supported by a grant from Medtronic, Inc.

4. Site Principal Investigator. Accelerated Arterial Thrombolysis with Alfimiprase.

Sponsor: Nuvelo

5. Principal-Investigator – RENAISSANCE Genesis Renal Artery Stent Trial, Boston

Scientifics Inc. Sponsor

6. Sponsor and Mentor – RSNA Medical Student Departmental Program Grant,

"Acetic Acid pH Diffusion Mapping in an Ex Vivo Calf Liver Model", investigator Mr.

Daniel Huang.

7. Sponsor Investigator – Percutaneous Acetic Acid Injection for the Ablation of

Hepatic Malignancies, multicenter, IND # 59,478, supported by a grant from CIRREF

8. Principal Investigator – BEACH Carotid Stenting Trial, sponsored by Boston

Scientific Inc.

9. Sponsor Investigator – Single Bolus TNKase Venous Thrombolysis Phase ½

Feasibility Trial (SBVT), #BB-IND 10018, multicenter, supported by a grant from

Genentech Inc.

10. Sub-Investigator – Boston Scientific WALLGRAFT™ Endoprosthesis for

Complex Iliac Stenosis and Occlusion Trial

11. Sponsor Investigator – High-Risk Carotid Artery S.M.A.R.T. Stent Registry,

IDE # G990283 and G990283/A1

12. Sub-Investigator – Bard Impra covered hemodialysis access stent trial

13. Sub-Investigator – Intratherapeutics Renal Artery Stenting Trial

14. Principal Investigator – Cordis Covered Biliary Stent Trial

15. Principal Investigator – AVE Suboptimal Renal Angioplasty Registry (SOAR)

16. Principal Investigator – Bard Memotherm Iliac Nitinol Stent Trial (MINS)

17. Principal Investigator -- Evaluation of the Potential for Renal Salvage Using

Percutaneous Transluminal Renal Angioplasty and Vascular Stenting, WMC

18. Principal Investigator -- Balloon Expandable Renal Stents for Renal Artery

Stenosis, WMC

19. Co-investigator -- Genentech Peripheral r-tPA Thrombolysis Registry,

Muhlenberg Hospital Center Sub-Investigator – Boston Scientific WALLGRAFT™

Endoprosthesis Aneurysm and Trauma Clinical Trial

10) Departmental and University Committees

Cancer Committee, Holy Name Medical Center, 2007-present

Credentialing Committee, Holy Name Medical Center, 2009-present

Patient Safety Committee, Holy Name Medical Center, 2009-present

Columbia-Presbyterian Vascular Service Line Executive Committee, 2004-2005

Co-chair, Columbia-Presbyterian Vascular Service Line Quality Assurance Committee,

2004-2005

Alternate Member, Columbia-Presbyterian Institutional Review Board, 2003-2005


Resident Education Advisory Committee and Research Activities Subcommittee,

NYMC, 1996-1997

NYMC Committee for the Protection of Human Subjects (Institutional Review Board),

9/99 – 7/00

WMC Research Protocol Review Committee, 8/98 – 7/00

WMC Procedure Review Committee, 2/00 – 7/00

Danbury Hospital Institutional Review Board, 7/00 – 8/01

11) Teaching Experience and Responsibilities

1. “Teacher of the year” award, NYMC Dept. of Radiology, 1995-1996, 1997-1998

2. Numerous annual didactic lectures to Radiology Residents and fellows, 1995-present

3. Board review courses for Vascular and Interventional Radiology, 1992- present (New York

Medical College, Cornell Weill Medical Campus, St. Vincent‟s Medical Center, Columbia

Presbyterian)

4. Course Director – “Innovations in stroke prevention – new approaches to diagnosis and

treatment”. Rye, NY, May 1999

5. Course Director – “Innovations in the peripheral and renal vascular disease – new

approaches to diagnosis and treatment”. Rye, NY, October 1999

6. Course Director – “Innovations in women‟s health and imaging”. Rye, NY, March 2000

7. Course Director – “Peripheral vascular disease: A practicum for primary care physicians”.

Danbury, CT, November 2000

8. Course Director – Peripheral Arterial Disease: Clinical Decision Making And Practice

Development, Teaneck, NJ, December 2006

9. Course Director – SIR Multimodality PAD meeting, Washington D.C., October 2007

10. Course Director – Vascular Medicine and Intervention 2 (VMI2), Newark, NJ, April 2008

11. Course Director – Self Assessment Module Course – Peripheral Arterial Occlusive Disease

Perspectives on Diagnosis and Treatment – RSNA, December 2008, Chicago, IL

Presentations:

1. Aortic Graft Workshop - Speaking on IVC Filters: How to Place and Retrieve them

Safely. Presented at CRT, February 2011

2. Primer to Endovascular Interventions - Re-entry Devices and Case Review. Presented at

CRT, February 2011

3. Intermittent Claudication - Lower Extremity Arterial Imaging: The Role of CTA and

MRA. Presented at ACCF, February 2011

4. Critical Limb Ischemia - Critical Limb Ischmeia: Below the Knee Endovascular Options.

Presented at ACCF, February 2011

5. AAA Screening / Imaging / Diagnosis. Presented at ACCF, February 2011

6. DEBATE - CON: Medical Therapy Preferred over Endovascular Therapy to Preserve

Renal Function in Ischemic Nephropathy. Presented at ACCF, February 2011

7. Stroke and Venous Thromboembolic Disease - Axial Imaging (CT/MR) of DVT or PE.

Presented at ACCF, February 2011


8. Aortic Graft Workshop - Speaking on IVC Filters: How to Place and Retrieve them

Safely. Presented at CRT, February 2011

9. Primer to Endovascular Interventions. Speaking - Re-entry Devices and Case Review.

Presented at CRT, February 2011

10. Case Presenter – Coffee with the Experts: Dialysis Intervention. Presented at ISET,

January 2011

11. Technical Considerations in Contemporary Peripheral Arterial and Venous Stenting –

Speaker at Boston Scientific ISET Luncheon, January 2011

12. Radial Access for Dialysis Intervention (techniques and applications of radial access)

Presented at ISET, January 2011

13. Who Benefits Today from Renal Stenting? (renal and visceral intervention) Presented at

ISET, January 2011

14. Case Presenter - Coffee with the Experts: Tibial Interventions. Presented at ISET, January

2011

15. Subintimal Techniques for Tibial Arteries (critical limb ischemia) Presented at ISET,

January 2011

16. Collaborative Care – What‟s the team approach to the treatment of PAD? Speaker NY

Podiatry Show, January 2011

17. Moderator – General Medical Therapeutics / CV Risk factor Management. Vascular

Medicine and Intervention IV Conference, December 2010

18. Current Indications for Vascular Screening by Territory: Guidelines and

Recommendations. AAA. Presented at Vascular Medicine and Intervention IV

Conference, December 2010

19. Current Indications for Vascular Screening by Territory: Guidelines and

Recommendations. Renal Artery Disease. Presented at Vascular Medicine and

Intervention IV Conference, December 2010

20. Predictors of Outcomes in Patients with Asymptomatic Carotid Stenosis. Presenter,

Vascular Medicine and Intervention IV Conference, December 2010

21. Decision Making in the Vascular Patient; Renal and Visceral. Moderator, Vascular

Medicine and Intervention IV Conference, December 2010

22. Outcomes of Interventional Management for Ischemic Nephropathy and Cardiac

Syndromes. Presenter, Vascular Medicine and Intervention IV Conference, December

2010

23. Ischemic Leg Conference Holy Name Medical Center – Speaker on Pathophysiology and

Treatment Options. December 2010

24. Renal Intervention: New Devices Workshop. Presenter at VEITH/AIM November, 2010

25. Renal Artery Stenosis: Medication, Mechanical Intervention or Both. Presented at TCT,

September 2010

26. Iliac and SFA Intervention. Moderator at TCT, September 2010

27. Endovascular Interventions: Open Issues in Endovascular Interventions – Moderator.

TCT, September 2010

28. Incontrovertible Reasons for Renal Artery Stenting. Presented at TCT, September 2010

29. Management of Critical Limb Ischemia. Presented to Hudson/Essex/Union Counties DO

Societies, September 2010

30. Epidemiology, Natural History and methods of Diagnosis. Presented at VIVA, October

2010


31. Intervention of Iliofemoral DVT. Presented at VIVA, October 2010

32. Drip, Spray, Aspirate, Blenderize or Buzz: Does Technique Make a Difference in DVT

Thrombolysis. Presented at VIVA, October 2010

33. Do It with Liquid: Sclerotheraphy of Spider and Saphenous Venins. Presented at VIVA,

October 2010

34. Renal Atherembolism: Embolic Protection. Presented at Complex Coronary and Vascular

Cases 2010, NY, NY, June 2010

35. Renal Case Vignette and Iliac Case Vignette. Presented at SIR, March 2010.

36. Practice Development – Freestanding IR Practice: Using Hospital Coverage Contracts to

Help Fund the Opening of a Free Standing Interventional Radiology Center. Partnering

with Other Entities to Open a Free Standing Interventional Radiology Practice. Presented

at SIR, March 2010.

37. SVC Syndrome. Presented at CRF, February 2010.

38. Class Differences and Complications between IVC Filters. Presented at CRF, February

2010.

39. When to Use CTA and MRA for Renovascular Disease. Presented at ACCF, February

2010.

40. Renal Stents for Ischemic Nephrophathy: The Evidence Base. Presented at ACCF,

February 2010.

41. AAA Screening/Imaging/Diagnosis. Presented at ACCF, February 2010.

42. Carotid Artery Imaging Studies: Appropriate use of CTA and MRA. Presented at ACCF,

February 2010.

43. Targeted Medical Therapy for Peripheral Arterial Disease. Presented at Vascular

Medicine and Intervention III Symposium, December 2009.

44. Interventional Management of Renal Artery Stenosis – Who Benefits. Presented at

Vascular Medicine and Intervention III Symposium, December 2009.

45. Asymptomatic Carotid Stenosis-Medical Therapy First? Presented at Vascular Medicine

and Intervention III Symposium, December 2009.

46. Peripheral Arterial Occlusive Disease: Perspectives on Diagnosis and Treatment –

Spectrum of Disease and Treatments Options presented at RSNA, December 2009.

47. Status of the TACIT Trial: Will we ever know the truth about how asymptomatic patients

with carotid stenosis should be treated? Will the stimulus package save the day for

TACIT? Presented at VEITH/AIM Conference, November 2009.

48. State of the Art in protecting renal function with angiographic procedures that require

contrast. Presented at VEITH/AIM Conference, November 2009.

49. Improving renal perfusion during contrast studies may help preserve renal function in

patients with renal insufficiency. Presented at VEITH/AIM Conference, November 2009.

50. Renal Artery Disease Management with an emphasis on endovascular approaches at Ohio

State University College of Medicine

51. Procedural Techniques to Optimize Acute Safety & Long Term Outcomes of DeNovo and

Restenotic Renal Artery Stenting. Presented at TCT 2009

52. Renal Artery Stenting: A Critical Review of the Data and US and Interventional

Guidelines. Presented at TCT 2009

53. Pro: Controversies in Carotid Stenting. Presented at TCT 2009

54. How to manage severely calcified SFA disease: Rules of engagement and case reviews.

Presented at the CICT Conference, July 2009


55. Aortic Stent Grafts: The effects of design on technical performance. Presented at the

CICT Conference, July 2009

56. How to Manage Delayed EVAR Complications: Case reviews. Presented at the CICT

conference, July 2009.

57. Embolization Therapy: Indications, Tools and Techniques. Presented at the CICT

conference, July 2009

58. PAD: Current Diagnostic Strategies – Vascular Laboratory and Axial Imaging.

Cardiovascular Research Technologies, Washington, D.C., March 2009

59. Infrapopliteal Endovascular Interventions: What is the Modern Data? Cardiovascular

Research Technologies, Washington, D.C., March 2009

60. Thoracic Aortic Pathology: Strategies for Diagnosis. Cardiovascular Research

Technologies, Washington, D.C., March 2009

61. Renal Artery in Stent Restenosis: How to Handle? Cardiovascular Research

Technologies, Washington, D.C., March 2009

62. What Will it Take to Shift the Treatment of Iliofemoral DVT to Intervention?

Cardiovascular Research Technologies, Washington, D.C., March 2009

63. Non-invasive Angiography for limbs: CTA vs. MRA. American College of Cardiology

Foundation (ACCF) – The Clinical Practice of Peripheral Arterial Disease: Key

Components for Cardiovascular Specialists. Washington, D.C., February 2009

64. Invasive Angiography for lower extremity diagnosis. ACCF. Washington, D.C.,

February 2009

65. ALI: ACC/AHA Guideline Review. ACCF. Washington, D.C., February 2009

66. Renal non-invasive angiography: CTA vs. MRA. ACCF. Washington, D.C., February

2009

67. Renal stents for ischemic nephropathy: the evidence base. ACCF. Washington, D.C.,

February 2009

68. AAA screening/imaging/diagnosis. ACCF. Washington, D.C., February 2009

69. Treatment of Chronic Total Occlusions. New England Society of Angiography and

Interventional Radiology. February, 2009

70. Optimizing and Protecting Renal Function in Angiographic Procedures. ISET,

Hollywood, FL, January 2009

71. Current Status of Stenting, Recent CMS Decisions. ISET, Hollywood, FL, January 2009

72. SIR Webinar: The Scientific Evidence for PAD Interventions. New York, NY, Dec 2008

73. Peripheral Arterial Occlusive Disease: Perspectives on Diagnosis and Treatment Spectrum

of Disease and Treatment Options. RSNA, Chicago, Dec 2008

74. Integrated Science to Practice: Vascular / Interventional Keynote Speaker – PAD

Interventions. RSNA, Chicago, Dec 2008

75. Hemodialysis Access – Distal radial artery access is best. AIM 2008, NYC, Nov 2008

76. RAS: We don‟t know the answers yet and a prospective randomized trial is needed. AIM

2008, NYC, Nov 2008

77. What is the status of TACIT? Will it ever be done? VEITH 2008, NYC, Nov 2008

78. Balloon Occluded Retrograde Transvenous Obliteration of Varices: An underutilized IR

procedure. AIM 2008, NYC, Nov 2008

79. Global Management of Critical Limb Ischemia – Team Components and Wound Care.

VIVA 2008, Las Vegas, NV, Sept 2008


80. Does the CORAL Trial really matter and can we really wait for those results? VIVA

2008, Las Vegas, NV, Sept 2008

81. Status of Renal Artery Intervention. PACES 2008, Bridgewater, NJ, Sept 2008

82. Chronic Limb Ischemia: State of the Art. PACES 2008, Bridgewater, NJ, Sept 2008

83. Renal artery stenosis and cardiovascular risk. Vascular Medicine and Intervention 2

(VMI2), Newark, NJ, April 2008

84. Carotid artery stenting in asymptomatic patients. Vascular Medicine and Intervention 2

(VMI2), Newark, NJ, April 2008

85. Update on the current use of IVC filters in 2008. American College of Cardiology I2

Summit, Chicago, IL, March 2008

86. Super absorbent polymers for embolization of tumors in the liver. International

Symposium on Endovascular Therapy, Hollywood, FL, January 2008

87. New Ways of Preventing Contrast-induced Nephropathy in Intervention. International

Symposium on Endovascular Therapy, Hollywood, FL, January 2008

88. Drug Absorbing and Drug Eluting Beads for Cancer Embolization – is there a role?

Advanced Interventional Management Meeting, New York, NY, November 2007

89. Renal Interventions: New Techniques Workshop. Advanced Interventional Management

Meeting, New York, NY, November 2007

90. The Transatlantic Asymptomatic Carotid Intervention Trial (TACIT): What is the Status

and Will This Ever Get Funded? VEITH Meeting, New York, NY, November 2007

91. EPD‟s for renal procedures -- where do we stand? ACE meeting, New York, NY,October

2007

92. Medicare Coverage for Renal Stenting: Carotid Redux? Transcatheter Cardiovascular

Therapeutics, Washington, D.C., October 2007

93. My worst outcomes: endovascular strategies. Transcatheter Cardiovascular Therapeutics,

Washington, D.C., October 2007

94. Targeted Medical Treatment Goals and Initial Management in the Claudicant with SFA

Disease. SIR Multimodality PAD Meeting, Washington, D.C., October 2007

95. Role of EPD‟s for Renal Procedures. SIR Multimodality PAD Meeting, Washington,

D.C., October 2007

96. Natural History of Asymptomatic Carotid Artery Stenosis. SIR Multimodality PAD

Meeting, Washington, D.C., October 2007

97. Embolic Protection in Renal Artery Interventions: Breakthrough or Bust? VIVA 2007,

Las Vega, NV, Sept 2007.

98. Drug-eluting Stents, Bioabsorbable stents, Drug-coated Balloons and Local Drug

Delivery: Are These Ever Going to Play a Role? VIVA 2007, Las Vegas, NV, Sept 2007.

99. Renal Artery Revascularization – Techniques and Tips. Dialog Session. VIVA 07. Las

Vegas, NV, Sept 2007.

100. Radiofrequency Ablation of Lung Neoplasms. Presented at the University of Cincinnati

Annual Symposium on Lung Cancer, Cincinnati, Ohio, September 2007

101. Neuroanatomy for the Interventionalist. Presented at the NJ Annual Carotid Endovascular

Symposium, New Jersey, March 2007.

102. Acute Thrombus Management in Arteries and Veins: Essential Catheters, Filters and

Lytic Strategies for the Interventionalist. Presented at American College of Cardiology

Annual Meeting I2 Summit, New Orleans, LA, March 2007.


103. Intervention for Venous Thromboembolism. Presented at American College of

Cardiology Annual Meeting I2 Summit, New Orleans, LA, March 2007.

104. Radiofrequency Ablation of Lung Neoplasms. Visiting Professor Lecture, Jefferson

University Medical Center, Philadelphia, PA, March 2007.

105. Renovascular Disease: Emerging Paradigms in Diagnosis and Treatment. Visiting

Professor Lecture, North Shore Long-Island Jewish Healthcare Network, NY, January

2007.

106. Distal Protection during Renal Artery Stenting: Always, Sometimes or Never? Presented

at the International Symposium for Endovascular Therapy, Hollywood, FL, January 2007.

107. Renal Artery Stenosis and Cardiovascular Risk: A New Paradigm. Presented at the

International Symposium for Endovascular Therapy, Hollywood, FL, January 2007.

108. Renal Interventions Case Review Workshop. Presented at the International Symposium

for Endovascular Therapy, Hollywood, FL, January 2007.

109. Update on the CORAL Trial. AIM meeting, November 2006, NYC, NY

110. Renal Artery Intervention Workshop. AIM meeting, November 2006, NYC, NY

111. Preventing contrast-induced nephropathy: a new tool for an old problem. AIM meeting,

November 2006, NYC, NY

112. Renal stenting trial update (completed and ongoing): evidence based medicine.

TCT2006. Washington, DC, October 2006

113. When (or whether) to consider protected renal artery stenting. TCT2006. Washington,

DC, October 2006.

114. DES and Embolic Protection for Renal Artery Intervention: Is it Worth the Trouble and

Expense? ACE Oct 2006, New York, NY

115. Renal Artery Stenting: How To Do It in 2006. ACE Oct 2006, New York, NY

116. Embolic protection in renal artery intervention: is this really necessary? VIVA 2006, Las

Vegas, September 2006

117. Vena Cava Filters: New Devices Mean Retrievable for All? VIVA 2006, Las Vegas,

September 2006

118. Long Segment (TASC D) SFA stenting is NOT inferior to bypass surgery – Hot Debate

IV. VIVA 2006, Las Vegas, September 2006

119. CT and MRA for peripheral vascular disease. Peripheral Arterial Disease Training. June

2006. NYC

120. Stent-Grafts: Balloon expandable and self expanding. Peripheral Arterial Disease

Training. June 2006. NYC

121. Renal and Mesenteric Intervention. Peripheral Arterial Disease Training. June 2006.

NYC.

122. Distal Protection. ISET 2006. January 2006.

123. Cost Effectiveness of Femoral Intervention: ISET 2006. January 2006, Miami FL

124. Renovascular Interventions. ISET 2006. January 2006, Miami FL.

125. Renovascular Interventions Workshop Coordinator. 13th

Annual Advanced Interventional

Management (AIM) Symposium, NYC, November 2005

126. Systemic Administration of Nanoparticle Paclitaxel: A Novel Approach To Preventing

Restenosis. Presentation at the 13th Annual Advanced Interventional Management

Meeting, NYC, November 2005


127. Update On The CORAL Trial: Renal Angioplasty With Protection Versus Medical

Management. Presentation at the 13th Annual Advanced Interventional Management

Meeting, NYC, November 2005

128. What Kind of Benefits Can Be Expected from Renal Artery Stenting?. Presentation at

Transcatheter Cardiovascular Therapeutics (TCT), Washington, D.C., October 2005

129. Nanoparticle Paclitaxel Assisted Revascularization of the SFA. Presentation at

Transcatheter Cardiovascular Therapeutics (TCT), Washington, D.C., October 2005

130. Embolic Protection in Renal Artery Interventions. Presentation at the 3rd

Annual Vascular

Interventional Innovations Meeting, Las Vegas, NV September 2005

131. Common, Yet Avoidable Complications – presentation of a case of geniculate

pseudoaneurysm during tibial intervention. Presentation at the 3rd

Annual Vascular

Interventional Innovations Meeting, Las Vegas, NV September 2005

132. Renal Stenting with Distal Protection. Presented at the 8th

Annual Live Symposium of

Complex Coronary and Vascular Cases, N.Y., June 2005

133. Moderator, Scientific Session – Interventional Radiology: Hepatic Interventions.

American Roentgen Ray Society, May 2005

134. Update on Renal and Peripheral Revascularization. Presentation at the American

Roentgen Ray Society, May 2005

135. Is there a role for embolic protection in renal interventions? Plenary presentation at 30th

Annual meeting of SIR, New Orleans, April 2005

136. Peri/Intra procedural Medication in the Vascular Patient. Categorical presentation at the

30the Annual meeting of SIR, New Orleans, April 2005

137. Renal Interventions. Invited speaker at 2005 AVIR Annual meeting, New Orleans, April

2005

138. Renovascular Interventions. Workshop faculty at the 30th annual meeting of SIR, New

Orleans, April 2005

139. “Outcomes in patients failing femoral angioplasty” Invited commentary, 30th annual

meeting of SIR, New Orleans, April 2005

140. “Cardiovascular Risk in Renovascular Disease”, presented at the 17th

Annual Meeting of

the International Symposium on Endovascular Therapy. Miami Beach, January 2005.

141. “Renal Artery Angioplasty and Stenting: Is Distal Protection Necessary?”, presented at

the 17th

Annual Meeting of the International Symposium on Endovascular Therapy.

Miami Beach, January 2005.

142. “Iliac Occlusions: Should the Treatment be Surgical or Endovascular?, presented at the

17th

Annual Meeting of the International Symposium on Endovascular Therapy. Miami

Beach, January 2005.

143. Renovascular Interventions Workshop faculty at the Advanced Interventional

Management (AIM) Symposium, New York, November 2004

144. “Indications and Techniques for Renal Artery Intervention: Is Embolic Protection

Necessary?” Presented at 12th

Annual Advanced Interventional Management Symposium,

November 2004.

145. “Developing an Outpatient Practice: Avoiding Pitfalls”. Presented at 12th

Annual

Advanced Interventional Management Symposium, November 2004.

146. “Renal Stenting with Embolic Protection: The Next Frontier? Presented at Medtronics

sponsored evening symposium, Transcatheter Cardiovascular Therapeutics, Sept 2004.


147. “Novel Therapies for Long Total SFA Occlusions”. Presented at Transcatheter

Cardiovascular Therapeutics, Sept 2004.

148. “Perspectives on DES for Peripheral Vascular Disease: from SIRROCCO to GREAT”.

Feature Presentation, Transcatheter Cardiovascular Therapeutics, Sept 2004.

149. “Renal Artery Stenosis: Diagnosis, Treatment and Outcomes”. Presented at the 8th

Annual Keystone Meeting of Hemodialysis and Renal Failure. Kiawah Island, S.C. July

2004.

150. “Fistulography: Normal or Abnormal?” Presented at the 8th

Annual Keystone Meeting of

Hemodialysis and Renal Failure. Kiawah Island, S.C. July 2004.

151. “The „Bare Metal‟ Stent: Its role in HD Access”. Presented at the 8th

Annual Keystone

Meeting of Hemodialysis and Renal Failure. Kiawah Island, S.C. July 2004.

152. “Drug Eluting Stents in Renal Artery Stenosis”. Presented at the 8th

Annual Keystone

Meeting of Hemodialysis and Renal Failure. Kiawah Island, S.C. July 2004.

153. “State-of-the-art: Protected Renal Angioplasty and Drug-Eluting Stents”. Presented at

the 7th

Annual Live Symposium of Complex Coronary and Vascular Cases, N.Y., June

2004.

154. “SFA Intervention”. Keynote Speaker, 33rd

Japanese Society of Angiography and

Interventional Radiology (JSAIR), Tokyo, Japan, May 2004.

155. “Drug-Eluting Stents”. Invited Speaker and Moderator, American Roentgen Ray Society

(ARRS) Annual Meeting, May 2004.

156. “Clinical Outcomes with Embolic Protection in Renal Stenting”. Presented at Medtronic

booth at the 29th

Annual Meeting of SIR, Phoenix, AZ, March 2004

157. “Technology Update – Results from the SIRROCCO and GREAT Trials”. Presented at

Cordis booth at the 29th

Annual Meeting of SIR, Phoenix, AZ, March 2004

158. Update on Renovascular Disease. Presented at Behavior Hypertension Center and

Department of Medicine, Columbia-Presbyterian Medical Center, March 2004

159. “Clinical Trials Network” 29th

annual meeting of the Society of Interventional

Radiology, invited plenary talk, Phoenix, AZ, March 2004

160. Renovascular Interventions. Workshop faculty at the 29th

annual meeting of the Society

of Interventional Radiology, Phoenix, AX, March 2004

161. “Drug-Eluting Stents and Strategies for SFA Revascularization”. Virginia Angiography

Society, January 2004

162. “Percutaneous and Transarterial Embolization of Liver Tumors: State-of-the-Art.”

Advanced Interventional Management (AIM) Symposium, November 2003

163. Renovascular Interventions: Monorail Technology. Workshop faculty at the Advanced

Interventional Management (AIM) Symposium, New York, November 2003

164. Interventional Oncology. Workshop faculty at the Advanced Interventional Management

(AIM) Symposium, New York, November 2003

165. “Chemical Ablation of Hepatic Tumors”, Interventional Oncology: Current Practice and

Future Trends, October 2003

166. “Renal Artery Stenting – Early and Long Term Results”, Controversial Aspects in Renal

and Carotid Stenting Meeting, September 2003

167. “Drug Eluting Stents”, Winston-Salem Angio Society, July 2003

168. “Drug Eluting Stents and SFA Revascularization”, Chesapeake Angio Society, June 2003

169. “Coated Stents”, Detroit Angio Society, June 2003


170. “Practice Development and New Interventions”, Cordis Tech Forum, Warren, NJ May

2003

171. “Renal Interventions” 13th Annual AVIR Annual Meeting, invited lecture, Salt Lake City,

UT, May 2003

172. "Noninvasive Screening Tests for Renal Artery Stenosis: Are There Reliable Predictors of

Outcomes?" Society of Interventional Radiology, invited plenary talk, Salt Lake City,

UT, April 2003

173. “New Tools and Agents for Percutaneous Tumor Injections”, Advanced Interventional

Management Symposium, invited speaker, New York, NY, November 2002

174. Renovascular Interventions: Monorail Technology and Distal Protection. Workshop

faculty at the Advanced Interventional Management (AIM) Symposium, New York,

November 2003

175. “Drug-eluting stents: results of the SIRROCCO trial and future considerations”, invited

speaker, New England Angio Club, October 2002

176. “Chemical Ablation: PEI and Acetic Acid”, Current Strategies in the Treatment of

Hepatic Malignancies Conference, invited speaker, Tysons Corner, VA, September 2002

177. “Acetic Acid Ablation of Liver Tumors”, M.D. Anderson Cancer Center Interventional

Radiology Research Seminar Series, invited speaker, August 2002

178. “Drug-eluting stents”, invited speaker, Houston Angio Club, August 2002

179. “Drug-eluting stents”, invited speaker, Dallas Angio Club, August 2002

180. Moderator – “Practice Management”. Scientific Session, 27th

annual meeting of the

Society of Cardiovascular and Interventional Radiology, Baltimore, MD, April 2002

181. Panelist – “Workbook for the Interventional Radiologist who wants to participate in a

clinical trial”. Categorical course, 27th

annual meeting of the Society of Cardiovascular

and Interventional Radiology, Baltimore, MD, April 2002

182. Renovascular Interventions. Workshop faculty at the 27th

Annual Meeting of the Society

of Cardiovascular and Interventional Radiology, Baltimore, MD, March 2002

183. Current status of Vascular Interventional Radiology Research: Results of a SCVIR

Member Survey. Presented at the 27th

Annual Meeting of the Society of Cardiovascular

and Interventional Radiology, Baltimore, MD, March 2002

184. Stent Based Local Pharmacotherapy: Sirolimus. Categorical session, 27th

Annual Meeting

of the Society of Cardiovascular and Interventional Radiology, Baltimore, MD, March

2002

185. Current Status of VIR Research: What Needs to be Done? Categorical session, 27th

Annual Meeting of the Society of Cardiovascular and Interventional Radiology,

Baltimore, MD, March 2002

186. Faculty, “Workbook for the Interventional Radiologist Who Wants to Participate in a

Clinical Trial”, categorical course at the 27th

Annual Meeting of the Society of

Cardiovascular and Interventional Radiology, Baltimore, MD, March 2002

187. Peripheral and Renovascular Disease – Current Status. Department of Medicine Grant

Rounds, Columbia Presbyterian Medical Center, February 2002

188. Regional Cancer Therapy. Presentation to multidisciplinary Tumor Board, Lawrence

Hospital, Bronxville, NY, February 2002

189. Renovascular Disease: Selection and Results of Stenting. Department of Medicine Grand

Rounds, Lawrence Hospital, Bronxville, NY, January 2002


190. Renal Artery Stenting: Patient Selection and Results. Department of Urology Grand

Rounds, Columbia Presbyterian Medical Center, New York, January 2002

191. Renal Artery Stenosis: Patient Selection and Outcomes. New England Angiography

Society, Boston, MA, September 2001

192. Coordinator – Interventional Oncology and Angiology: Research to Practice. Three

categorical sessions for the 26th Annual Meeting of the Society of Cardiovascular and

Interventional Radiology, San Antonio, TX, March 2001

193. Moderator – Interventional Angiology: Research to Practice. Categorical session, 26th

annual meeting of the Society of Cardiovascular and Interventional Radiology, San

Antonio, TX March 2001

194. Moderator – Interventional Oncology: Research to Practice. Categorical session, 26th

annual meeting of the Society of Cardiovascular and Interventional Radiology, San

Antonio, TX March 2001

195. Coordinator – Research categoricals for the 27th annual meeting of the Society of

Cardiovascular and Interventional Radiology, Baltimore, MD April 2002 – (4.5 program

hours) – “New Horizons in Interventional Oncology”, “New Horizons in Vascular

Research”, “Building a Research Program”

196. Current Status of Renal Artery Stent Trials. Invited speaker, plenary sessions, 26th

Annual Meeting of the Society of Cardiovascular and Interventional Radiology, San

Antonio, TX, March 2001

197. Hemodialysis Access Interventions. Workshop faculty at the 26th Annual Meeting of the

Society of Cardiovascular and Interventional Radiology, San Antonio, TX, March 2001

198. Renovascular Interventions. Workshop faculty at the 26th Annual Meeting of the Society

of Cardiovascular and Interventional Radiology, San Antonio, TX, March 2001

199. Interventional Treatment of Renovascular Disease. 5th Annual Hemodialysis and Venous

Intervention Symposium, Keystone, CO, February 2001

200. Renal Angioplasty and Stenting at the Turn of the Millennium. Grand Rounds, Dept. of

Medicine, Danbury Hospital, August 2000

201. Renovascular Interventions. Coordinator and Workshop faculty at the 25th Annual

Meeting of the Society of Cardiovascular and Interventional Radiology, San Diego, CA,

March 2000

202. Peripheral and Renal Vascular Disease in Women. At “Innovations in woman‟s health

and imaging”, Rye, NY, March 2000

203. Renal Angioplasty and Stenting: State-of-the-Art. Washington Hospital Center 6th

Annual Midwinter CME Meeting, Telluride, CO, March 2000

204. Agrawal U, Rundback J, Rizvi A, et al. Angioplasty and Stent Placement For Transplant

Renal Artery Stenosis: A 7-Year Experience. 25th Annual Scientific Meeting of the

Society of Cardiovascular and Interventional Radiology. San Diego, CA, March 2000

205. Renal angioplasty and stenting workshop. Seventh Annual Conference on Current issues

and New Techniques in Interventional Radiology. NY, NY, November 1999

206. Peripheral vascular disease – current concepts in management. Westchester Medical

Center, Dept of Internal Medicine Grand Rounds, October 1999

207. Percutaneous Hemodialysis access management. New York Hospital – Bronx Division,

Dept of Nephrology Grand Rounds, October 1999


208. Renal angioplasty and stenting: state-of-the-art. Clinical practice symposium --

Innovations in peripheral and renal vascular disease: new approaches to diagnosis and

treatment. Rye, NY, October 1999

209. Innovations in vascular intervention: carotid, renal, and femoral stents. St. Vincent‟s

Medical Center, Bridgeport CT, Dept of Medicine Grand Rounds, September 1999

210. Carotid stenting: current status. 22nd Annual Symposium on Vascular Surgery.

Tarrytown, NY, September 1999

211. Carotid stenting: the future of carotid revascularization? Clinical practice symposium on

“Innovations in stroke prevention – new approaches to diagnosis and treatment”. Rye,

NY, May 1999

212. Innovations in vascular intervention: carotid, renal, and femoral stents. Sound Shore

Medical Center, Dept of Medicine Grand Rounds, April 1999

213. Balloon angioplasty or stent placement in patients with renal insufficiency: a

retrospective comparison of outcomes. 24th Annual Meeting of the Society of

Cardiovascular and Interventional Radiology, Tampa, FL, March 1999

214. Renovascular Interventions. Coordinator and Workshop faculty at the 24th Annual

Meeting of the Society of Cardiovascular and Interventional Radiology, Tampa, FL,

March 1999

215. Renal artery stents: 1st approach or last resort? New York Medical College Dept of

Surgery Grand Rounds, November 1998

216. Renal artery stents: 1st approach or last resort? Presented at the Chesapeake Valley

angiography society, Washington, D.C., October 1998

217. Percutaneous Management of Ischemic Nephropathy. Presented at the 21st Annual

Symposium on Vascular Surgery, Tarrytown, N.Y., September 1998

218. Balloon Angioplasty and Stents in the Management of the Failed and Failing

Hemodialysis Access. Presented at the 2nd Northeastern Conference on Vascular Access

for Hemodialysis, New York, N.Y., May 1998

219. Renovascular Interventions. Coordinator and Workshop faculty at the 23rd Annual

Meeting of the Society of Cardiovascular and Interventional Radiology, San Francisco,

CA., March 1998

220. Current Status of Supra-and Infrainguinal Vascular Stents. Surgical Grand Rounds, New

York Medical College, November 1997

221. Current Status of Endovascular Renal Revascularization: presented at the 3rd Annual New

York Symposium on Vascular and Endovascular Techniques, September 1997

222. Supra- and Infrainguinal Stents – Techniques and Results. Vascular Surgery Grand

Rounds, Maimonides Medical Center, May 1997

223. Diagnostic and Treatment Strategies for Renal Artery Stenosis. Presented at the 12th

Annual Westchester Vascular Symposium, March 1997

224. Introduction to Vascular Interventions. Workshop faculty at the 22nd Annual Meeting of

the Society of Cardiovascular and Interventional Radiology, Washington D.C., March

1997

225. Renal Artery Stents for the Management of Renal Insufficiency. Nephrology Grand

Rounds, North Shore University Medical Center, January 1997

226. Treatment Options for Ischemic Nephropathy. Surgical Grand Rounds, New York

Medical College, November 1996


227. Palmaz Stenting of Stenotic Renal Arteries in Patients with Ischemic Nephropathy.

Presented at the Annual Meeting and Postgraduate Course of the Cardiovascular and

Interventional Radiological Society of Europe, September 1996

228. Treatment Options for Ischemic Nephropathy. Presented at the 20th Annual Symposium

on Vascular Surgery, September 1996

229. Therapeutic Options in Patients with Renovascular Hypertension and Ischemic

Nephropathy. Presented at the 20th Annual Convention and CME Seminar of the

Karnataka State Medical and Dental Alumni Association of America, August 1996

230. Rozenblit G, Del Guercio LM, Savino J, Rundback JH. Transmesenteric-Transfemoral

Method of TIPS Placement. Presented at the 21st Annual Society of Cardiovascular and

Interventional Radiology Meeting, March 1996

231. Percutaneous Therapies for Renal Artery Stenosis. Nephrology Grand Rounds, New York

Medical College, May 1995

232. Outpatient Percutaneous Endovascular Procedures. presented at the 20th Annual Society

of Cardiovascular and Interventional Radiology Meeting, March 1995

233. Fluoroscopically Guided Peritoneal Catheter Placement for Intraperitoneal Chemotherapy.

presented at 18th Annual Society of Cardiovascular and Interventional Radiology

Meeting, February 1993

234. Gray RJ, Rundback JH, et. al. Ergonomic Vascular Access Needle (EVAN) with Blood

Containment Capability. Presented at 19th Annual Society of Cardiovascular and

Interventional Radiology Meeting, March 1994

235. Gray RJ, Horton KM, Dolmatch BL, Rundback JH, Aquino AO, Light JA. Wallstents for

Hemodialysis Access. Presented at the 80th Annual Meeting of the Radiology Society of

North America, November 1994

12) Other Professional Activities

Section Editor, Peripheral Vascular Disease, Journal of Vascular and Interventional

Radiology, 2009-present

Reviewer, Journal of Vascular and Interventional Radiology (JVIR) 1997-2009

[Distinguished Reviewer 1997-1998, 1998-1999, 1999-2000, 2002-2003, 2003-2004]

Review, American Journal of Roentgenology

Reviewer, Catheterization and Cardiovascular Interventions

Reviewer, Kidney International

Reviewer, Society of Interventional Radiology Foundation Grant Program

Abstract Reviewer, American Heart Association (AHA) Annual Meetings, 2000-

present

Former Reviewer, Heart Disease – A Journal of Cardiovascular Medicine

Fellowship panel, Resident Career Workshop of the New York State Radiological

Society, 1996 –1999

Guest editor, June 1999 issue of “Techniques in Vascular and Interventional

Radiology” on “Renovascular Interventions”


13) Publications

A. Original, peer reviewed articles

1. Reflections on TACIT, what’s next for CREST, and a Close Look at the Field of Interventional Radiology. An Interview - Endovascular Today 2010 August. Volume 9, No 8. 82-80

2. Laird JR, Rundback J, Zierler RE, Becker GJ, O’Shaughnessy C, Shuck JW, Allie D, Olin JW, Cantwell-Gab K, Thomas J. Safety and Efficacy of Renal Artery Stenting Following Suboptimal Renal Angioplasty for DeNovo & Restenotic Ostial Lesions: Results from a Nonrandomized Prospective Multi Center Registry. JVasc Interv Radiol. 2010.Mar 19

3. Martin LG, Rundback JH, Wallace MJ, Candella JF, Angle JF, Kundu S, Miller DL, Wojak JC, Society of Interventional radiology (SIR). Quality improvement guidelines for angiography, angioplasty and stent placement for diagnosis and treatment of renal artery stenosis in adults. JVasc Interv Radiol. 2010 Apr; 21 (4) 421-30

4. Rundback JH, Zybulewski A, Manno J. Permanent or temporary IVC filtration with a novel double-ring anchoring technology optional nitinol filter. Expert Rev Med Devices. 2010 Jan;7(1):11-9.

5. In support of AHA indications for screening angiography at the time of

coronary Arteriography: understanding the recommendations and clarifying the

goals. Vascular Med 2009 Aug; 14 (3) 277-81. Rundback, JH

6. Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity

revascularization: state of the art. Gray BH, Conte MS, Dake MD, Jaff MR,

Kandarpa K, Ramee SR, Rundback J, Waksman R; American Heart Association

Writing Group 7. Circulation. 2008 Dec 16;118(25):2864-72.

7. Murphy KJ, Kelekis DA, Rundback J, et al.Development of a Research Agenda

for Skeletal Intervention: Proceedings of a Multidisciplinary Consensus

Panel.Cardiovasc Intervent Radiol. 2008 Mar 21

8. Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial

chemoembolization for primary hepatocellular carcinoma in patients at high

risk. J Vasc Interv Radiol 2007; 18 (12): 1517-1526.

9. ACCF/SCAI/SVS/SVMB/SIR/ASITN Clinical Expert Consensus Document on

Carotid Stenting : A Report of the American College of Cardiology Foundation

Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2007

Jan 2;49(1):126-70 / Vasc Med. 2007 Feb;12(1):35-83.

10. Spies JB, Rundback JH, Ascher S, Bradley L, Goodwin SC, Hovsepian DM,

Myers ER, Pelage JP, Pron G, Siskin GP, Stewart EA, Worthington-Kirsch R,

Hume KM, Strain C, Gomolka B; SIR Foundation. Development of a research

agenda for uterine artery embolization: proceedings from a multidisciplinary

research consensus panel. J Vasc Interv Radiol. 2006 Dec;17(12):1871-9

11. Indications for renal arteriography at the time of coronary arteriography: a

science advisory from the American Heart Association Committee on

Diagnostic and Interventional Cardiac Catheterization, Council on Clinical

Cardiology, and the Councils on Cardiovascular Radiology and Intervention

and on Kidney in Cardiovascular Disease. Circulation. 2006 Oct

24;114(17):1892-5. Epub 2006 Oct 9

http://www.ncbi.nlm.nih.gov/pubmed/20021237?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1

http://www.ncbi.nlm.nih.gov/pubmed/20021237?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17185681&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum




12. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R,

Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W,

Dworkin L. Stent revascularization for the prevention of cardiovascular and

renal events among patients with renal artery stenosis and systolic hypertension:

rationale and design of the CORAL trial. Am Heart J. 2006 Jul;152(1):59-66.

13. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto

AH, Jamerson KA, D'Agostino RB. Cardiovascular Outcomes with Renal

Atherosclerotic Lesions (CORAL) Study: Rationale and Methods.J Vasc Interv

Radiol. 2005 Oct;16(10): 1295-1300.

14. Goldberg SN, Bonn J, Dodd G, Dupuy D, Geschwind JH, Hicks M, Hume KM,

Lee FT, Lewis CA, Lencioni RA, Omary RA, Rundback JH, Silverman S,

Dorfman GS. Society of interventional radiology interventional oncology task

force: interventional oncology research vision statement and critical assessment

of the state of research affairs. J Vasc Interv Radiol. 2005 Oct; 16(10): 1287-

1294.

15. Weinberger JZ, Rundback JH, Ratchford EH. Regulatory approval of

percutaneous peripheral revascularization devices in the United States: is the

horse still in the barn? Am J Ther. 2005 Mar-Apr;12(2):186-91.

16. Vendantham S, Rundback JH, Khilnani N, et al. Development of a Research

Agenda For Endovenous Treatment Of Lower Extremity Venous Reflux:

Proceedings From A Multidisciplinary Consensus Panel. J Vasc Interv Radiol.

2005 Dec;16(12):1575-9.

17. Vendantham S, Rundback JH, Khilnani N, et al. Development of a Research

Agenda For Endovascular Treatment Of Venous Thromboembolism:

Proceedings From A Multidisciplinary Consensus Panel. J Vasc Interv Radiol.

2005 Dec;16(12):1567-73.

18. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper

JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J;

American Heart Association. Atherosclerotic vascular disease conference:

Writing Group III: pathophysiology. Circulation. 2004 Jun 1;109(21): 2617-25.

19. *Rundback JH, Dorfman G, Farahani K, et al. Development of a Research

Agenda for Interventional Oncology: Proceedings from an Interdisciplinary

Consensus Panel. JVIR 2004 Jan;15(1 Pt 1): 7-12.

20. *Rundback JH, Wright K, McClennan G. Current status of Interventional

Radiology research: results of a CIRREF survey and implications for future

research strategies. JVIR 2003; 14 (9): 1103-1110.





21. *Rundback JH, Sacks D, Venbrux A, et al. Guidelines for the Use of Renal

Artery Stents in Clinical Trials. Circulation 2002 Sep 17; 106 (12): 1572-1585.

(Co-published in JVIR 2002; 13 (10): 959-974. Reprinted in JVIR 2003

Sep;14(9 Pt 2):S477-92)

22. Duda SH, Poerner TC, Wiesinger B, Rundback JH, Tepe G, Wiskirchen J,

Haase KK. Drug eluting stents – potential applications for peripheral arterial

occlusive disease. JVIR 2003; 14: 291-301.

23. *Rundback JH, Murphy TP, Cooper C, Weintraub JL. Chronic renal ischemia:

pathophysiologic mechanisms of cardiovascular and renal disease. J Vasc Interv

Radiol. 2002 Nov;13(11):1085-1092.

24. *Murphy TP, Rundback JH, Cooper C, Kiernan MS. Chronic renal ischemia:

implications for cardiovascular disease risk. J Vasc Interv Radiol 2002

Dec;13(12):1187-1198.

25. *Rundback JH, Weintraub JL. Renal Vascular Interventions. Seminars in

Roentgenology 2002; 37:312-326

26. *Martin LG, Cardella J, Rundback JH, et al. Quality Improvement Guidelines

For Angiography, Angioplasty And Stenting For The Diagnosis And Treatment

Of Renal Artery Stenosis In Adults. JVIR 2002; 13: 1069-1083.

27. Poplausky MR, Rozenblit G, Rundback JH, Crea G, Maddineni S, Leonardo R.

Swan-Ganz catheter-induced pulmonary artery pseudoaneurysm formation:

three case reports and a review of the literature. Chest. 2001 Dec; 120(6):

2105-2111.

28. Krishna Kandarpa, MD, PhD, Gary J. Becker, MD, M.G. Myriam Hunink, MD,

PhD, Thomas O. McNamara, MD, John H. Rundback, MD, David W. Trost,

MD, Thomas A. Sos, MD, Maurice R. Poplausky, MD, Charles P. Semba, MD,

Wendy J. Landow, MPH. Transcatheter Interventions for the Treatment of

Peripheral Atherosclerotic Lesions: Part I. JVIR 2001; 12:683-695.

29. *Rundback JH, Crea G, Rozenblit GN, Poplausky M, Maddineni S, Agrawal U,

Matalon TAS. The difficult renal angioplasty. Cathet Cardiovasc Interv 2001;

52: 120-126.

30. *Rundback JH, Rizvi A, Rozenblit GN, Poplausky M, Maddineni S, Crea G,

Agrawal U, Olson C, Matalon TAS. Percutaneous stent-graft management of

renal artery aneurysms. JVIR 2000; 11: 1189-1193.

31. Poplausky M, Nguyen GK, Rozenblit GN, Rundback JH, Moorthy CR,

Maddineni S, Crea G, Saleh N, Ghoniem A. Intravascular brachytherapy via the


inferior vena cava: an adjunctive treatment for pancreatic cancer. J Vasc Interv

Radiol. 2000 Jun; 11(6): 729-732.

32. Rozenblit GN, Eisenberger E, Rundback JH, Poplausky M, Savino J, Lebovics

E, Crea G, Maddineni S. Percutaneous cholecystoduodenostomy: a case report.

JVIR 2000; 11: 629-633.

33. *Rundback JH, Rizvi A, Tomasula J. Percutaneous treatment of transplant renal

artery stenosis: techniques and results. Techniques in Vascular and

Interventional Radiology, 1999 June; 2 (2): 91-97.

34. *Crea G, Rundback JH, Maddineni S. Managing complications of renovascular

interventions. Techniques in Vascular and Interventional Radiology, 1999

June; 2 (2): 98-106.

35. *Rundback JH, Manoni T, Rozenblit GN, Poplausky MP, Crea G, Maddineni S.

Balloon angioplasty or stent placement in patients with renovascular disease: a

retrospective comparison of outcomes. Heart Disease 1999; 1: 121-125.

36. Rozenblit GN, DelGuercio LRM, Rundback JH, Poplausky MR, Lebovics M.

Peritoneal-Urinary Drainage for Treatment of Refractory Ascites: A Pilot

Study. JVIR 1998; 9: 998-1005.

37. *Rundback JH, Gray RJ, Sugarbaker P. Peritoneal Catheters for Intraperitoneal

Chemotherapy. Semin Intervent Radiol 1998; 15: 402-414.

38. *Rundback JH, Leonardo R, Rozenblit G, Poplausky MR. Vein Rupture

Complicating Hemodialysis Access Angioplasty: Percutaneous Treatment and

Outcomes in Seven Patients. AJR 1998; 171: 1081-1084.

39. *Rundback JH, Gray R, Rozenblit G, Poplausky M, Babu S, Shah P, Butt K,

Tomasula J, Garrick R, Goodman A, Dolmatch B, Horton K. Renal Artery

Stent Placement for the Management of Ischemic Nephropathy. JVIR 1998; 9

(3): 413-420.

40. *Poplausky MR, Rozenblit G, Pavlov M, Rundback JH. Angioplasty of an

Unusual Aortic Coarctation. Catheterization and Cardiovascular Diagnosis

1998; 43:77-80.

41. Rozenblit G, Lebovics E, Savino JA, Rundback JH, Bashir S. Observation on

Intrarenal and Intraperitoneal Pressures in Patients with Tense Ascites:

Feasibility of Unassisted Ascites Drainage into the Urinary System. Min

Invas Ther & Allied Technol 1997;6:83-86.

42. *Rundback JH, Jacobs JL. Percutaneous Renal Artery Stent Placement for

Hypertension and Azotemia: Pilot Study. Am J Kid Dis 1996 Aug; 28 (2):

214-219.


43. Rozenblit G, DelGuercio LRM, Savino JA, Rundback JH, Cerabona TD,

Policastro AJ, Artuso DP. Transmesenteric-transfemoral method of

intrahepatic portosystemic shunt placement with minilaparatomy. JVIR 1996;

7: 499-506.

44. Gray RJ, Horton KM, Dolmatch BL, Rundback JH. Use of Wallstents for

Hemodialysis Access-related Venous Stenoses and Occlusions Untreatable with

Balloon Angioplasty. Radiology 1995 May, 195(2): 479-484.

45. Dolmatch BL, Gray RJ, Horton KM, Rundback JH, Kline ME. Treatment of

Anastamotic Bypass Graft Stenosis with Directional Atherectomy: Short-term

and Intermediate-term Results. JVIR 1995, 6(1): 105-113.

46. Gray RJ, Rundback JH, Dolmatch BL, Horton KM. Ergonomic Vascular

Access Needle with Blood Containment Capability: Clinical Evaluation during

Arterial Access Procedures. JVIR 1995, 6(1): 115-118.

47. *Rundback J, Gray RJ, Dolmatch B, Horton K. Fluoroscopically Guided

Peritoneal Catheter Placement for Intraperitoneal Chemotherapy. JVIR 1994,

5:161-165.

48. Rundback JH, Rosenberg ZS, Solomon G. The Radiographic Features of

Rheumatoid Arthritis in HLA-B27 Positive Patients. Skel Rad 22:263-267,

1993.

B. Case Reports

1. Duwe K, Rundback JH. Traumatic mesenteric venous pseudoaneurysm:

successful treatment with percutaneous stent-grafting. JVIR (in press)

2. *Rundback JH, Rozenblit GN, Poplausky MR. Jejunal artery angioplasty and

coronary stent placement for acute mesenteric ischemia. Cardiovasc Intervent

Radiol 2000 Sep-Oct; 23(5):410-412.

3. *Rundback JH, Chugtai S, Rozenblit G, Poplausky MR, Panageas E.

Traumatic Mesenteric Pseudoaneurysm: Diagnosis and Transcatheter

Treatment. Cathet Cardiovasc Intervent 1999; 48: 217-219.

4. *Rundback JH, Shah P, Rozenblit G, et al. Livedo Reticularis,

Rhabdomyolysis, Massive Intestinal Infarction and Death Following Carbon

Dioxide Arteriography. J Vasc Surg 1997 Aug; 26:337-340.


5. Sclafani SJA, Rundback JH. “Life-Saving” Traumatic Aortopulmonary Fistula

Resulting from Penetrating Thoracic Trauma. Emergency Radiology 1997;

4:41-45.

6. Rundback J, Goldfarb C, Ongseng F: Gallium-67 Imaging in Candidal

Esophagitis. Clin Nucl Med 15(1):38-40, 1990.

C. Reviews, chapters and editorials

1. Rundback JH, Weintraub JL. Renal Angioplasty and Stenting. In Image-

Guided Interventions / Matthew A. Mauro … [et al.] – 1st Edition. Saunders

Elsevier, Philadelphia 2008, pp. 715-724.

2. Weintraub JL, Rundback JH. Chemical Ablation of Liver Lesions. In Image-

Guided Interventions / Matthew A. Mauro … [et al.] – 1st Edition. Saunders

Elsevier, Philadelphia 2008, pp. 1523-1532.

3. Rundback J. Renal revascularization in diabetics: few facts, firm convictions,

forward momentum. Catheter Cardiovasc Interv. 2007 May 1;69(6):908-9.

4. Rundback J. A novel approach to mesenteric revascularization, creative

thinking, and the interventional toolbox. Catheter Cardiovasc Interv. 2007 Mar

1;69(4):553

5. The SFA Roundtable: Interventional experts John Laird, MD; Takao Ohki, MD;

and John H. Rundback, MD, discuss the current state of endovascular

treatments for SFA disease, including the ideal uses for today‟s available

technologies. Endovascular Today. 2007 Jan.

6. Mennitt, KW, Rundback JH. MRA Evaluation of Intravascular Stents.

Endovascular Today. 2006 Jan; 54-60.

7. What is Peripheral Arterial Disease? Review article in “Keeping in

Circulation”, the official newsletter of the Vascular Disease Foundation, Fall

2005, vol. 5, No. 4

8. Cost-Effectiveness of Phased Revascularization Initiated with Percutaneous

Cryoplasty, Boston Scientific Monograph, June 2006

9. *Rundback JH. Selective iliac stenting: pro! In Endovascular Today,

May 2005


10. *Weintraub JL, Rundback JH,. Hemodialysis angioplasty and Stents. In, A

Multidisciplinary Approach for Hemodialysis Access. Gray R, Sands J, eds.

Williams & Wilkins 2002, pp. 161-169.

11. *Rundback JH, Malloy PC. The use of catheters for hemodialysis: overview.

In, A Multidisciplinary Approach for Hemodialysis Access. Gray R, Sands J,

eds. Williams & Wilkins 2002, pp. 253-260.

12. *Rundback JH, Rozenblit GR, Poplausky MR. Renal artery stenting. SCVIR

Syllabus: Peripheral Arterial Interventions, 2nd

edition. Society of

Cardiovascular and Interventional Radiology: Virginia 2001, pp. 279-293.

13. *Sacks D, Rundback JH, Martin LG. Renal angioplasty/stent placement and

hypertension in the year 2000. JVIR 2000; 11: 949-953.

14. *Rundback JH, Matalon TAS. Around here, you have to run as fast as you

can… Heart Disease (editorial) 2000; 2 (2): 101

15. *Lee B, Rundback JH, Poplausky MR, eds. Imaging of the Acutely Ill and

Surgical Patient. McGraw-Hill, New York, 2000 Chapters (as primary author):

Head and Neck Imaging, Abdomen and Pelvis Imaging, Extremity Imaging

16. *Rundback JH, Trost D, Spinosa D. Renovascular interventions. In Society of

Cardiovascular and Interventional Radiology 25th Annual Scientific Meeting

Workshop Book. March, 1999.

17. *Rundback JH, Trost D, Matsumoto AH. Renovascular interventions. In

Society of Cardiovascular and Interventional Radiology 24th

Annual Scientific

Meeting Workshop Book. San Francisco, CA. March 20-25, 1999.

18. *Rundback JH, Leonardo R. Noncoronary Vascular Stents. In Stent-Grafts:

Current Clinical Practice. Dolmatch B. and Blum U., eds. Thieme: New York,

1999, pp 1-21.

19. Rozenblit GN, DelGuercio LR, Rundback JH, Poplausky MR. A fresh look at

the treatment of ascites. JVIR 1999; 10: 991-992.

20. *Rundback JH. Mesenteric Venous Thrombosis: Successful treatment by

intraarterial lytic therapy. Letter to the editor. JVIR 1999; 10: 98-99.

21. *Rundback JH, Poplausky MR, Rozenblit G. Iliofemoral Venous Thrombolysis

after Failed Surgical Thrombectomy (letter to the editor). JVIR 1998; 9

(5):852-853.


22. *Rundback JH. Renovascular interventions. In Society of Cardiovascular and

Interventional Radiology 23rd

Annual Scientific Meeting Workshop Book. San

Francisco, CA. February 8 – March 5, 1998, pp447-462.

23. *Rundback JH, Poplausky MR, Kotval PS. Subclavian Steal Syndrome. In the

SCVIR Noninvasive Vascular Diagnosis Syllabus. Lippincott-Raven Press,

February 1998.

24. Gray RJ, Horton KM, Dolmatch BL, Rundback JH, et al. Wallstents for the

Failing Hemodialysis Access. In Vascular Access for Hemodialysis – IV.

Edited by ML Henry and RM Ferguson. W.L. Gore and Assoc., 1995.

25. Dolmatch BL, Rundback JH, Horton KM, Gray RJ. Percutaneous Treatment of

Aortic Disease. in Diseases of the Aorta. Lindsay J Jr., ed. Lea and Febinger:

Philadelphia 1994.

26. Dolmatch BL, Gray RJ, Horton KM, Rundback JH. Diagnostic Imaging in the

Evaluation of Aortic Disease in Diseases of the Aorta. Lindsay J Jr., ed. Lea

and Febinger: Philadelphia 1994.

27. Dolmatch BL, Horton KM, Gray RJ, Rundback JH. Imaging Studies Used for

Aortic Evaluation in Diseases of the Aorta. Lindsay J Jr., ed. Lea and

Febinger: Philadelphia 1994.

D. Abstracts

1. *Rundback JH, Weintraub JL. Cost-Effectiveness of Phased Revascularization

Initiated with Percutaneous Cryoplasty (poster at Transcatheter Cardiovascular

Therapeutics, Washington, DC, 2005)

2. Kothary N, Rundback JH, Haskal ZJ, Susman J, Weintraub JL. High Risk

Chemoembolization. (presented at the 30th annual meeting of the Society of

Interventional Radiology, New Orleans, 2005)

3. Cura M, Rundback JH, Weintraub JL, Susman J, Kothary N. Renal artery

angioplasty and stenting using Distal Protection Devices. (presented at the 29th

annual meeting of the Society of Interventional Radiology, Phoenix AZ, 2004)

4. Mennitt KW, Rundback JH, Prince MR. Optimizing MR Angiography of Racer

Stents. The 2004 Magnetic Resonance Angiography Workshop. Presentation of

findings. London, Ontario, Canada; October 6, 2004.

5. Shahin I, Rundback JH, Haskal ZJ, Weintraub JL, Susman J. Renal Artery

Stenosis (RAS) as an Independent Risk Factor for Cardiovascular Events. JVIR


(featured abstract at the 29th

annual meeting of the Society of Interventional

Radiology, Phoenix AZ, 2004)

6. *Rundback JH, Hwang D, Susman J, Haskal ZJ, Weintraub JL. pH Diffusion

of Acetic Acid in an Ex-Vivo Calf Liver Model. JVIR (poster at the 29th

annual

meeting of the Society of Interventional Radiology, Phoenix AZ, 2004)

7. *Rundback JH, Rozenblit GR, Gyftopoulos S, Susman J, Haskal ZJ, Weintraub

JL, Poplausky M, Kothary N. Acetic Acid Ablation of Hepatic Tumors: Mid

Term Results. JVIR (moderated poster at the 29th

annual meeting of the Society

of Interventional Radiology, Phoenix AZ, 2004)

8. *Rundback JH, Hanjan T, Susman J, Haskal ZJ, Weintraub JL. Imaging after

Acetic Acid Ablation. JVIR (poster at the 29th

annual meeting of the Society of

Interventional Radiology, Phoenix AZ, 2004)

9. Cura MA, Haskal ZJ, Lefkowitch J, Susman J. Weintraub J. Rundback JH et al.

Control of Budd Chiari Syndrome Using TIPS: Clinicopathologic Findings

Using Stent-Grafts and Wallstents. Society of Interventional Radiology Annual

Meeting. Phoenix AZ.

10. *Rundback JH, Rozenblit GN, Susman J. Acetic acid ablation of liver tumors.

JVIR 2003; 2(part 2): S49

11. Susman J, Haskal ZJ, Weintraub JL, Rundback JH. Predictive Value of Biliary

Stress Manometry in Living-Donor Liver Transplant Recipients with Biliary

Strictures. Annual Meeting of the Cardiovascular and Interventional Radiology

Society of Europe, September 2003 Antalya, Turkey.

12. Haskal ZJ, Goudie S, Weintraub J, Susman J, Rundback J, Schmidt L. Single

center early U.S. experience using the Viatorr TIPS endoprosthesis. JVIR

2002; 2 (part2): S34

13. Susman J, Haskal ZJ, Foley IH, Weintraub JL, Rundback JH, Guarrera J, et al.

Efficacy of percutaneous dilation of anastamotic biliary strictures in living-

donor liver transplant recipients. JVIR 2003; 2(part2): S14

14. Weintraub JL, Haskal ZH, Susman J, Rundback J. 3-D Computed Rotational

Interventional Radiology Imaging: Peripheral Vascular and Biliary

Applications. Computer Exhibit, RSNA 2001, Chicago, IL, December 2001

15. *Agrawal U, Rundback JH, Rizvi AZ, Rozenblit GN, Poplausky MR, Butt K, et

al. Angioplasty and stent placement for transplant renal artery stenosis: a 7-

year experience. JVIR 2000; 11 (no. 2, part 2): 179-180 (abstract)


16. Rozenblit GN, Del Guercio LRM, Poplausky MR, Rundback JH, Savino JA,

Maddineni S, Crea G, Magalski JJ. Transmesenteric method of intrahepatic

portosystemic shunt placement. Gut 1999; 45 (suppl IV): A58 (abstract)

17. *Rundback JH, Folander HL, Granson MA. Outpatient Percutaneous

Endovascular Procedures, Abstr. JVIR 1995, 6(1): 12.

18. Gray RJ, Rundback JH, et al. Ergonomic Vascular Access Needle (EVAN)

with Blood Containment Capability, Abstr. JVIR 1994, 5(1):39.